Literature DB >> 10949543

Cloning of the mouse desmoglein 3 gene (Dsg3): interspecies conservation within the cadherin superfamily.

H Ishikawa1, K Li, K Tamai, D Sawamura, J Uitto.   

Abstract

Desmoglein 3 is a cadherin-like calcium-dependent cell adhesion molecule expressed primarily in suprabasal keratinocytes of the epidermis. In this study, we have cloned the full-length cDNA and characterized the entire gene structure for the mouse desmoglein 3 gene (Dsg3). Isolation of overlapping cDNA clones, together with 5' and 3' rapid amplification of cDNA ends (RACE), allowed delineation of the entire coding sequence. The transcriptional initiation site was confirmed by primer extension and reverse transcription polymerase chain reaction analysis. The entire cDNA consisted of 6407 bp with an open reading frame of 2979 bp, and the deduced polypeptide contained 993 amino acids. Comparison of mouse and human desmoglein 3 amino acid sequences demonstrated 85.6% homology. Computer analysis suggested the presence of a transmembrane segment, 5 potential calcium binding sites, and a RAL motif which corresponds to the HAV motif, the potential site for homophilic interaction of typical cadherins. The mouse desmoglein 3 gene consisted of 15 exons in chromosome 18. Comparison of the intron-exon organization of Dsg3 with various cadherins from different species revealed remarkable conservation. This relatively high level of conservation both at the protein and genomic level suggests that desmoglein 3 plays an important role in keratinocyte cell-cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949543     DOI: 10.1034/j.1600-0625.2000.009004229.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

Review 1.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris.

Authors:  D Mimouni; M Blank; L Ashkenazi; Y Milner; M Frusic-Zlotkin; G J Anhalt; M David; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Protein kinase C isoenzymes differentially regulate the differentiation-dependent expression of adhesion molecules in human epidermal keratinocytes.

Authors:  Andrea Szegedi; Edit Páyer; Gabriella Czifra; Balázs I Tóth; Emese Schmidt; László Kovács; Peter M Blumberg; Tamás Bíró
Journal:  Exp Dermatol       Date:  2008-07-07       Impact factor: 3.960

4.  Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris.

Authors:  Jinmin Lee; Daniel K Lundgren; Xuming Mao; Silvio Manfredo-Vieira; Selene Nunez-Cruz; Erik F Williams; Charles-Antoine Assenmacher; Enrico Radaelli; Sangwook Oh; Baomei Wang; Christoph T Ellebrecht; Joseph A Fraietta; Michael C Milone; Aimee S Payne
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

5.  Relevance of differential immunogenicity of human and mouse recombinant desmoglein-3 for the induction of acantholytic autoantibodies in mice.

Authors:  S Kaithamana; J-L Fan; O Memar; K Li; J Uitto; G S Seetharamaiah; B S Prabhakar
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

6.  Desmoglein isoform distribution affects stratum corneum structure and function.

Authors:  P M Elias; N Matsuyoshi; H Wu; C Lin; Z H Wang; B E Brown; J R Stanley
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

7.  Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.

Authors:  Katharina Boch; Sören Dräger; Detlef Zillikens; Christoph Hudemann; Christoph M Hammers; Sabrina Patzelt; Enno Schmidt; Ewan A Langan; Rüdiger Eming; Ralf J Ludwig; Katja Bieber
Journal:  PLoS One       Date:  2021-11-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.